000			01979 a2200565 4500
005			20250517063317.0
264		0	_c20160906
008			201609s 0 0 eng d
022			_a1573-7217
024	7		_a10.1007/s10549-015-3638-2 _2doi
040			_aNLM _beng _cNLM
100	1		_aImamura, Michiko
245	0	0	_aHigh levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients. _h[electronic resource]
260			_bBreast cancer research and treatment _cDec 2015
300			_a521-31 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aAromatase Inhibitors _xtherapeutic use
650	0	4	_aBone Density Conservation Agents _xtherapeutic use
650	0	4	_aBreast Neoplasms _xblood
650	0	4	_aCollagen Type I _xblood
650	0	4	_aDenosumab _xtherapeutic use
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLymphatic Metastasis _xpathology
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aPeptides _xblood
650	0	4	_aPhosphopeptides _xblood
650	0	4	_aPostmenopause
650	0	4	_aProcollagen _xblood
650	0	4	_aPrognosis
700	1		_aNishimukai, Arisa
700	1		_aHiguchi, Tomoko
700	1		_aOzawa, Hiromi
700	1		_aYanai, Ayako
700	1		_aMiyagawa, Yoshimasa
700	1		_aMurase, Keiko
700	1		_aSakita, Isao
700	1		_aHatada, Takuya
700	1		_aTakatsuka, Yuichi
700	1		_aKatagiri, Toyomasa
700	1		_aMiyoshi, Yasuo
773	0		_tBreast cancer research and treatment _gvol. 154 _gno. 3 _gp. 521-31
856	4	0	_uhttps://doi.org/10.1007/s10549-015-3638-2 _zAvailable from publisher's website
999			_c25453380 _d25453380